{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5ef0ad954320b108b12f7e8d/6a5a0e5ef782764c4c4e6985?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Symposium | Panel discussion: Shifting the treatment paradigm in cGvHD","description":"<p>During the 8th International Chronic Graft-versus-Host Disease Symposium, the GvHD Hub held a symposium on May 22, 2026, titled Evolving treatment strategies in SR‑cGvHD: Optimizing patient selection across current and emerging therapies.  </p><p><br></p><p>The symposium closed with a panel discussion that included questions from the audience. The panelists, Zinaida Perić, Daniel Wolff, and Corey Cutler, shared their perspectives on several key topics, including applying learnings from the treatment of other diseases, and the role of combination therapy in cGvHD. </p><p><br></p><p>This educational resource is independently supported by Sanofi. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence.</p><p><br></p><p><br></p>","author_name":"Scientific Education Support"}